Utility of ELISA optical density values and clinical scores for the diagnosis of and thrombosis prediction in heparin-induced thrombocytopenia

Korean Journal of Laboratory Medicine

Volumn 31, Issue 1, 2011, Pages 1-8

  Kim, Seon Young ^a   Kim, Hyun Kyung ^a   Han, Kyou Sup ^a   Kim, Inho ^a   Yoon, Sung Soo ^a   Park, Seonyang ^a   Kim, Byoung Kook ^a  

^a Seoul National University   (South Korea)

Author keywords

Clinical scoring system; Heparin induced thrombocytopenia; Heparin platelet factor 4 antibody; Optical density value

Indexed keywords

ANTIBODY; HEPARIN; THROMBOCYTE FACTOR 4;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHEMICALLY INDUCED DISORDER; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PRESCHOOL CHILD; RISK; SENSITIVITY AND SPECIFICITY; SURVIVAL; THROMBOCYTOPENIA; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; AREA UNDER CURVE; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN; HUMANS; INFANT; MALE; MIDDLE AGED; PLATELET FACTOR 4; RISK; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 79959542130     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2011.31.1.1     Document Type: Article

References (16)

1. Greinacher A and Warkentin TE. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update. Thromb Res 2006;118:165-76. (Pubitemid 43816669)
2. Chong BH and Chong JJ. Heparin-induced thrombocytopenia. Expert Rev Catdiovasc Ther 2004;2:547-59. (Pubitemid 39069790)
3. Warkentin TE and Heddle NM. Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2003;2:148-57.
4. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006;4:759-65.
5. Greinacher A, Juhl D, Strobel U, Wessel A, Lubenow N, Selleng K, et al. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes. J Thromb Haemosl 2007;5:1666-73. (Pubitemid 47091409)
6. Warkentin TE, Sheppard JA, Moore JC, Moore KM, Sigouin CS, Kelton JG. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? J Lab Clin Med 2005;146:341-6. (Pubitemid 41712020)
7. Zwicker JI, Uhl L, Huang WY, Shaz BH, Bauer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparininduced thrombocytopenia. J Thromb Haemost 2004;2:2133-7. (Pubitemid 40185772)
8. Warkentin TE and Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:311S-37S.
9. Bakchoul T, Giptner A, Najaoui A, Bein G, Santoso S, Sachs UJ. Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 2009;7:1260-5.
10. Bryant A, Low J, Austin S, Joseph JE. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay. Br J Haematol 2008;143:721-6.
11. Janatpour KA, Gosselin RC, Dager WE, Lee A, Owings JT, Zhou J, et al. Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia. Am J Clin Pathol 2007;127:429-33. (Pubitemid 46806337)
12. Whitlatch NL, Perry SL, Ortel TL. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 2008;100:678-84.
13. Weiss BM, Shumway NM, Howard RS, Ketchum LK, Reid TJ. Optical density values correlate with the clinical probability of heparin induced thrombocytopenia. J Thromb Thrombolysis 2008;26:243-7.
14. Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost 2008;6:1304-12. (Pubitemid 352016309)
15. Mattioli AV, Bonetti L, Carletti U, Ambrosio G, Mattioli G. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies. Heart 2009;95:1350-4.
16. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000;96:1703-8. (Pubitemid 30661052)